See All Slides - tctmd.com

Slides

Presentation TCT 2013

Current Indications and Outcomes of Thrombolysis for Pulmonary Embolism

Presenter: Jeffrey Olin

October 27, 2013

Presentation TCT 2013

There is No Bull's-eye: Nerve Distribution and Location Patterns Are Not Specific in Humans

Presenter: Renu Virmani

October 27, 2013

Presentation TCT 2013

What Went Right and What Went Wrong—and What Should Have Been Done Differently? A Critical Appraisal

Presenter: Robert Sommer

October 27, 2013

Presentation TCT 2013

Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications

Presenter: Sahil Parikh

October 27, 2013

Presentation TCT 2013

FDA Perspectives on HBD: Past, Present, and Future (videotape)

Presenter: Jeff Shuren

October 27, 2013

Presentation TCT 2013

Device and Clinical Trial Update: Allegro/Iberis (Angiocare/Terumo)

Presenter: Xiongjing Jiang

October 27, 2013

Presentation TCT 2013

Stretching the Field and Upending the Norms: Below-the-Knee Percutaneous Intervention

Presenter: Gerald Dorros

October 27, 2013

Presentation TCT 2013

LAA Closure is Now Established - The Added Value of New Randomized Trials Would be Minimal!

Presenter: Matthew Price

October 27, 2013

Presentation TCT 2013

Intervention in Multiple Sclerosis for Chronic Cerebral Spinal Venous Insufficiency (CCSVI): Is It Worth the Effort Involved to Test It?

Presenter: Sumaira Macdonald

October 27, 2013

Presentation TCT 2013

Emerging Technologies for CLI: Advantages to Working Together

Presenter: Hiroyoshi Yokoi

October 27, 2013

Advertisement

Slides

Current Indications and Outcomes of Thrombolysis for Pulmonary Embolism

There is No Bull's-eye: Nerve Distribution and Location Patterns Are Not Specific in Humans

What Went Right and What Went Wrong—and What Should Have Been Done Differently? A Critical Appraisal

Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications

FDA Perspectives on HBD: Past, Present, and Future (videotape)

Device and Clinical Trial Update: Allegro/Iberis (Angiocare/Terumo)

Stretching the Field and Upending the Norms: Below-the-Knee Percutaneous Intervention

LAA Closure is Now Established - The Added Value of New Randomized Trials Would be Minimal!

Intervention in Multiple Sclerosis for Chronic Cerebral Spinal Venous Insufficiency (CCSVI): Is It Worth the Effort Involved to Test It?

Emerging Technologies for CLI: Advantages to Working Together

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content